Cipla receives final approval for generic anti-HIV drug
Cipla receives final approval for generic anti-HIV drug

Cipla receives final approval for generic anti-HIV drug

Gayathri Udyawar Article rating: 4.0

Global pharma major Cipla has received final approval from USFDA to market a generic equivalent of Tenofovir Disoproxil Fumarate 300mg tablets. The drug will be made available for commercial shipment in the US immediately. 

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 3.0

Overall volumes in futures & options currently stand at 1.88 crore contracts with a turnover of Rs. 17,50,208.42 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: No rating

Overall volumes in futures & options currently stand at 1.88 crore contracts with a turnover of Rs. 17,50,208.42 crore.

Index trend and stocks in action January 29, 2018
Index trend and stocks in action January 29, 2018

Index trend and stocks in action January 29, 2018

Karan Dsij Article rating: 5.0

Going forward, important support for the Nifty is placed around the level of 10,990, but if Nifty fails to hold this support level, then a correction is expected up to the levels of 10,930-10,900. On the upside, the high of 11,110 might act as immediate resistance for the Nifty, followed by 11,200. Top stocks to watch out: FIEM Industries, Vakrangee, Jagran Prakashan, Havells, FDC, Hind Copper, Capital First, Kokuyo Camlin, Prataap Snacks, Amrutanjan Healthcare, Bharat Forge, and Reliance Industries. 

Markets likely to witness a gap-up opening
Markets likely to witness a gap-up opening

Markets likely to witness a gap-up opening

Karan Dsij Article rating: No rating

Indian markets are expected to make an optimistic start on the back of firm global cues. The SGX Nifty suggests that the Nifty may open at 11,129 with a gap-up of 55 points. 

Averaging up, a good strategy to let your profits run
Averaging up, a good strategy to let your profits run

Averaging up, a good strategy to let your profits run

Prakash Patil Article rating: 4.0

Most of the investors think of averaging down their cost of acquisition when the stock price go down. What does an investor do when the price of stock goes up? Should they purchase more of the stock or book profit?

Rebalancing your portfolio of investments
Rebalancing your portfolio of investments

Rebalancing your portfolio of investments

Prakash Patil Article rating: No rating

If your portfolio of investments is tilted heavily either towards equity or fixed income investments, it is advisable to make suitable changesso that it becomes a more balanced portfolio that provides proper diversification.

Availing tax benefit on LTA
Availing tax benefit on LTA

Availing tax benefit on LTA

Prakash Patil Article rating: 5.0

If you are planning to go out on a holiday next summer, you can benefit from the leave travel allowance (LTA) paid by your employer and make your holiday more enjoyable.

Investing in rising interest rate scenario
Investing in rising interest rate scenario

Investing in rising interest rate scenario

Prakash Patil Article rating: 3.0

Read on to know what kind of strategy an investor should adopt to take advantage of the rising interest rates, if the RBI raises rates in 2018 and 2019.

Small towns rising!
Small towns rising!

Small towns rising!

Prakash Patil Article rating: No rating

It looks like AMFI’s aggressive campaign “Mutual Funds Sahi Hai” over the last one year has really worked wonders and drawn small town investors into the mutual fund fold.

RSS
First34683469347034713473347534763477Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR